Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.82
Bid: 3.70
Ask: 3.94
Change: 0.01 (0.26%)
Spread: 0.24 (6.486%)
Open: 3.81
High: 0.00
Low: 0.00
Prev. Close: 3.81
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Product Regulatory Approval In Brazil

18 Aug 2023 07:00

RNS Number : 7053J
Plant Health Care PLC
18 August 2023
 

18 August, 2023

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Brazil approves PHC279 to Control Diseases of Sugar Cane and Coffee

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce that its biochemical fungicide, PHC279, for the control of sugar cane and coffee disease has received federal approval in Brazil.

Brazil is the world's largest producer of sugar cane and coffee. In the 2023/24 season, the area planted with sugar cane in Brazil is forecast to be 9.8 million hectares and more than 2.5 million hectares for coffee. In the 2021/22 season, Brazilian farmers spent more than US$46m on the control of sugar cane diseases and more than US$127m on the control of coffee diseases. PHC279 was submitted for regulatory approval in December 2022 as a foliar-applied product for the control of sugar cane orange rust (Puccinia kuehnii) and coffee leaf rust (Hemileia vastatrix). PHC279 is the active ingredient in the Company's product Saori®, which is successfully being used in Brazil as a seed treatment for the control of soybean diseases.

 

PHC279 originates from the Company's PREtec technology platform (Vaccines for PlantsTM). Derived from natural proteins, PREtec is an environmentally friendly technology which stimulates crop growth, enhances the ability to withstand a variety of abiotic stresses, improves disease control, plant health and yield. The environmentally friendly profile and unique mode of action of PHC279 is expected to lead to its wide adoption by Brazilian sugar cane and coffee growers. The Company is currently in discussions with potential distribution partners in anticipation of product launch during 2024.

 

The regulatory process in Brazil for agricultural products involves detailed review and approval by three government agencies. The Ministry of Agriculture establishes a product's agronomic recommendations; the National Health Surveillance Agency checks for safety, while the Brazilian Institute of Environment and Renewable Natural Resources classifies the environmental hazard profile of the product, to ensure its use does not pose a threat to the environment. PHC279 passed through this process with approval from all three agencies in less than a year, confirming the Brazilian government's commitment to promoting effective and environmentally friendly products.

 

Plant Health Care continues to scale in markets around the world and is growing its relationships with major global distribution partners. The Company is on track to achieve revenue of $30 million by 2025 through the launch of new products and organic business growth through current and future distributor relationships.

 

Jeff Tweedy, CEO of Plant Health Care, said: ‟Building on the success of Saori use in soybeans and the continued growth of H2Copla use in sugar cane, this new registration will bring the benefits of PHC279 to sugar cane and coffee growers and expand Plant Health Care's current business in Brazil. This product will help Brazilian farmers sustainably produce crops and supports the Company's vision to be a leading global provider of peptides for agricultural production."

 

For further information, please contact: 

 Plant Health Care plc  Jeff Tweedy, CEO

 

+1 919 926 1600

 Cenkos Securities plc - Nomad & Broker  Neil McDonald / Pete Lynch

 

+44 (0) 131 220 9771

 SEC Newgate (Financial Communications)  Robin Tozer / Harry Handyside / George Esmond

+44 (0)7540 106 366 phc@secnewgate.co.uk

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. 

 

Find out more at www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGPUGURUPWGBM
Date   Source Headline
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.